Latest Stories

B
Screener

1 Cash-Burning Stock with Impressive Fundamentals and 2 We Question

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even bankruptcy.

Mar 13, 2026
W
Screener

3 of Wall Street’s Favorite Stocks We Approach with Caution

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Mar 13, 2026
S
Screener

1 Value Stock to Own for Decades and 2 We Ignore

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Mar 13, 2026
M
Screener

3 Healthcare Stocks We’re Skeptical Of

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 3.8%, nearly mirrorring the S&P 500.

Mar 13, 2026
B
Screener

3 Profitable Stocks We Steer Clear Of

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Mar 13, 2026
M
Screener

1 Profitable Stock to Consider Right Now and 2 We Brush Off

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Mar 13, 2026
B
Screener

3 Healthcare Stocks Walking a Fine Line

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 3.8% return has closely followed the S&P 500.

Mar 13, 2026
N
Screener

1 S&P 500 Stock Worth Your Attention and 2 Facing Headwinds

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Mar 13, 2026
L
Screener

2 Cash-Heavy Stocks with Exciting Potential and 1 Facing Challenges

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Mar 13, 2026
N
Screener

3 of Wall Street’s Favorite Stocks That Concern Us

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Mar 13, 2026